Back to Authors

Alkhouri, Naim

0000-0001-9872-2391

Mayo Clinic

From the NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Diego, La Jolla (R.L.), Velocity Clinical Research, Los Angeles (J.P.F.), and 89bio, San Francisco (M.D.G., S.F., G.D.A., C.L

Citations 1

Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

New England Journal of Medicine | June 24, 2023 | Volume: 389 | Issue: 11 | Pages: 998-1008

10.1056/nejmoa2304286 | PMID 37356033